Identification of reliable biomarkers of human papillomavirus 16 methylation in cervical lesions based on integration status using high-resolution melting analysis

BackgroundThe dynamic methylation of human papillomavirus (HPV) 16 DNA is thought to be associated with the progression of cervical lesions. Previous studies that did not consider the physical status of HPV 16 may have incorrectly mapped HPV 16 methylomes. In order to identify reliable biomarkers for squamous cervical cancer (SCC), we comprehensively evaluated the methylation of HPV 16 depending on the integration incidence of each sample.MethodsBased on the integration status of 115 HPV 16-infected patients (50 SCC, 30 high-grade squamous intraepithelial lesion [HSIL], and 35 low-grade squamous intraepithelial lesion [LSIL]) and HPV 16-infected Caski cell lines by PCR detection of integrated papillomavirus sequences, we designed a series of primers that would not be influenced by breakpoints for a high-resolution melting (HRM) PCR method to detect the genome methylation.ResultsA few regions with recurrent interruptions were identified in E1, E2/E4, L1, and L2 despite scattering of breakpoints throughout all eight genes of HPV 16. Frequent integration sites often occurred concomitantly with methylated CpG sites. The HRM PCR method showed 100% agreement with pyrosequencing when 3% was set as the cutoff value. A panel of CpG sites such as nt5606, nt5609, nt5615, and nt5378 can be combined in reweighing calculations to distinguish SCC from HSIL and LSIL patients which have high sensitivity and specificity (88% and 92.31%, respectively).ConclusionsOur research shows that combination of CpG sites nt5606, nt5609, nt5615, and nt5378 can be used as potential diagnosis biomarkers for SCC, and the HRM PCR method is suitable for clinical methylation analysis.

[1]  A. Fiander,et al.  Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[2]  D. Harper,et al.  HPV vaccines - A review of the first decade. , 2017, Gynecologic oncology.

[3]  M. Hoeckel,et al.  A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques , 2003, Oncogene.

[4]  X. Fang,et al.  Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism , 2015, Nature Genetics.

[5]  Christian B. Woods,et al.  Analysis of repetitive element DNA methylation by MethyLight , 2005, Nucleic acids research.

[6]  S. Wacholder,et al.  Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia , 2013, International journal of cancer.

[7]  L. Bonello,et al.  Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencing. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[8]  A. Fiander,et al.  Increased methylation of Human Papillomavirus type 16 DNA correlates with viral integration in Vulval Intraepithelial Neoplasia. , 2014, Journal of Clinical Virology.

[9]  H. Bernard,et al.  Human papillomavirus‐16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas , 2007, International journal of cancer.

[10]  Keegan D. Korthauer,et al.  Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer. , 2016, Carcinogenesis.

[11]  K A Baggerly,et al.  Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. , 2003, BioTechniques.

[12]  Yoshiyuki Watanabe,et al.  Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV‐associated head and neck squamous cell carcinoma cell lines , 2017, International journal of cancer.

[13]  C. Woodman,et al.  The natural history of cervical HPV infection: unresolved issues , 2007, Nature Reviews Cancer.

[14]  W. King,et al.  A refined, rapid and reproducible high resolution melt (HRM)-based method suitable for quantification of global LINE-1 repetitive element methylation , 2011, BMC Research Notes.

[15]  A. Valencia,et al.  The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. , 2008, Genome research.

[16]  M. von Knebel Doeberitz,et al.  Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions , 2013, International journal of cancer.

[17]  J. Edberg,et al.  A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia , 2011, Cancer.

[18]  E. J. Mayeaux,et al.  Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. , 2015, Gynecologic oncology.

[19]  C. Ohbayashi,et al.  L1 Gene Methylation in High-Risk Human Papillomaviruses for the Prognosis of Cervical Intraepithelial Neoplasia , 2012, International Journal of Gynecologic Cancer.

[20]  E. Speel,et al.  Viral load, gene expression and mapping of viral integration sites in HPV16‐associated HNSCC cell lines , 2015, International journal of cancer.

[21]  P. Lambert,et al.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Holm,et al.  Disruption of the E1 and E2 Reading Frames of HPV 16 in Cervical Carcinoma Is Associated with Poor Prognosis , 1998, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[23]  M. Hermann,et al.  Nogo-B is associated with cytoskeletal structures in human monocyte-derived macrophages , 2011, BMC Research Notes.

[24]  H. Bernard,et al.  Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation. , 2009, Virology.

[25]  Ratnesh K Singh,et al.  Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression. , 2011, Gynecologic oncology.

[26]  M. von Knebel Doeberitz,et al.  Detection of integrated papillomavirus sequences by ligation‐mediated PCR (DIPS‐PCR) and molecular characterization in cervical cancer cells , 2001, International journal of cancer.

[27]  P. Snijders,et al.  Methylation status of the E2 binding sites of HPV16 in cervical lesions determined with the Luminex® xMAP™ system. , 2012, Virology.

[28]  T. Ried,et al.  Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability , 2014, Genome research.

[29]  L. Rozek,et al.  Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia. , 2012, Journal of virological methods.

[30]  S. Wacholder,et al.  Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. , 2012, Journal of the National Cancer Institute.

[31]  A. Dobrovic,et al.  Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation , 2007, Nucleic acids research.

[32]  Nicolas Stransky,et al.  Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma , 2010, The Journal of pathology.

[33]  M. von Knebel Doeberitz,et al.  Differential Methylation of the HPV 16 Upstream Regulatory Region during Epithelial Differentiation and Neoplastic Transformation , 2011, PloS one.

[34]  Yong Shen,et al.  High-resolution melting analysis of HPV-16L1 gene methylation: A promising method for prognosing cervical cancer. , 2015, Clinical biochemistry.

[35]  S. de Sanjosé,et al.  Methylation of Human Papillomavirus Type 16 CpG Sites at E2-Binding Site 1 (E2BS1), E2BS2, and the Sp1-Binding Site in Cervical Cancer Samples as Determined by High-Resolution Melting Analysis–PCR , 2013, Journal of Clinical Microbiology.

[36]  Bornali Bhattacharjee,et al.  CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. , 2006, Virology.

[37]  Yang Ke,et al.  Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology , 2015, Oncotarget.

[38]  J. Meissner.  Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. , 1999, The Journal of general virology.

[39]  Masakazu Yamamoto,et al.  DNA methylation at hepatitis B viral integrants is associated with methylation at flanking human genomic sequences , 2015, Genome research.

[40]  R. Burk,et al.  Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. , 2011, Gynecologic oncology.

[41]  M. Schiffman,et al.  Chapter 5: Updating the natural history of HPV and anogenital cancer. , 2006, Vaccine.

[42]  Â. Pista,et al.  Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[43]  S. Wacholder,et al.  Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[44]  Lampros Dimitrakopoulos,et al.  A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples , 2012, BMC Cancer.

[45]  H. Bernard,et al.  Recombination of human papillomavirus‐16 and host DNA in exfoliated cervical cells: A pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression , 2010, Journal of medical virology.

[46]  H. Bernard,et al.  Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. , 2008, Virology.

[47]  S. Vinokurova,et al.  Systematic Review of Genomic Integration Sites of Human Papillomavirus Genomes in Epithelial Dysplasia and Invasive Cancer of the Female Lower Genital Tract , 2004, Cancer Research.